Position history for BAKER BROS. ADVISORS LP's holdings in ARROWHEAD PHARMACEUTICALS IN
BAKER BROS. ADVISORS LP holds 2M shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $124.9M as of 2026-Q1. The position was decreased (-8.4% shares). ARWR represents 0.7% of BAKER BROS. ADVISORS LP's portfolio.
Current Value
$124.9M
Current Shares
2M
Total Value Change
+$110.1M
Total Shares Change
+1.1M
Other major holders of ARWR: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BANQUE PICTET & CIE SA
Decreased |
| 2M |
-8.4% |
| $124.9M |
| 0.7% |
| $64.10 |
0 |
| 2025-Q4 | Increased | 2.2M | +30.2% | $144.4M | 0.8% | $67.25 | 54 |
| 2025-Q3 | Increased | 1.7M | +77.9% | $57.6M | 0.4% | $33.78 | 54 |
| 2025-Q2 | New | 939,174 | - | $14.8M | 0.1% | $16.08 | 47 |